172@29@17@144!~!172@29@0@53!~!|news|india|india-needs-to-knock-import-tariffs-niti-aayog-vice-chairman-arvind-panagariya-5351351.html!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsIndia
Last Updated : Jun 02, 2020 11:14 PM IST | Source: PTI

India needs to knock import tariffs: NITI Aayog Vice-Chairman Arvind Panagariya

Panagariya also pointed out that COVID-19 pandemic may lead to integration of global labour market.

PTI

Economic liberalisation has done good to India, and the country needs to knock down import tariffs imposed on many products in the last three years, former NITI Aayog Vice-Chairman Arvind Panagariya said on Tuesday.

Panagariya also pointed out that COVID-19 pandemic may lead to integration of global labour market.

"Liberalisation has done good to us. We are reversing something from which we benefited. I thought that in 1991, India had give up import substitution, but in the last three years, import tariff on many products have been raised," he said while addressing CII Annual Session 2020.

Close

"India needs to open up more and knock down import tariff imposed on many products in the last 3 years. We should bring tariff to 7 percent and sign trade agreement with the US, RCEP and European Union," he said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The eminent economist also expressed hope that down the line, India will sign trade agreements with the US, Regional Comprehensive Economic Partnership (RCEP) and the European Union.

Panagariya said India should continue to engage with Asia Pacific partners and get into RCEP as it prepares to take over the multinational companies from China in areas of textiles, footwear and other labour intensive sectors.

The professor of economics at Columbia University also pitched up for setting up Shenzhen-style coastal employment zones to boost manufacturing and creating employment.

Panagariya pointed out that there will be greater globalisation post COVID-19 pandemic in terms of integration of labour markets.

"Boundaries of the labour market will extend beyond H1-B visa as workers will work from their remote countries," he said, adding India could emerge as winner if it brings in major reforms in the education sector.

Panagariya observed that multilateralism had taken a hit even in the pre-COVID-19 days with bodies like the WTO Dispute Settlement mechanism becoming inoperative due to non-cooperation by the US.

"The COVID-19 crisis which has been currently sweeping the world is not likely to affect the process of globalisation," he stressed.

Panagariya said India needs 2-3 large employment zones with full autonomy to change rules.

"Today 44 percent of Indian workforce still involved in farming, you can't combat poverty without lot of farm workers moving out of farming to low skill industry," he argued.

Also, speaking at the event, Jeffrey Sachs, director of sustainable development, Columbia University, said that India made a big mistake in not joining the RCEP because this is an economic group catering to 3.2 billion people.

He stated that in light of the COVID-19  pandemic, countries sealing off their borders to prevent the virus from spreading in the country was not the same thing as reversing globalisation.

Follow our full coverage of the coronavirus pandemic here.
First Published on Jun 2, 2020 11:00 pm
Sections